Key result
Therapeutic inertia and medication noncompliance are major factors preventing optimal blood pressure goal attainment in patients with hypertension.
Highlights therapeutic inertia as a key barrier to achieving optimal blood pressure control in patients with hypertension.
Clinicians should address therapeutic inertia and noncompliance; leaves open optimal intervention strategies for prospective trials.
Optimal blood pressure (BP) control is still not being achieved for the majority of patients with hypertension. Although the topic of patient adherence to health care practitioner recommendations is less than desirable and medication noncompliance adds to the cost of health care, another issue that affects the ability to attain optimal BP control is therapeutic, or clinical, inertia, which is the failure of health care providers to initiate or intensify therapy when indicated. This paper will discuss therapeutic inertia and other issues that prevent BP goal attainment.
No takes yet. Share an insight, caveat, or question.
Jan Basile (2009) conducted a review in Hypertension. Therapeutic inertia was evaluated. Therapeutic inertia and medication noncompliance are major factors preventing optimal blood pressure goal attainment in patients with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: